Medical Pharmaceutical Supply – Topical Corticosteroids

The contract entails the supply of FDA-approved hydrocortisone cream at a 1 percent concentration, fully compliant with the National Stock Number 6505009262095 and adhering to commercial labeling standards for use in military medical settings. This product is intended to meet the specific pharmaceutical needs of the Department of Defense for topical corticosteroid treatment, ensuring consistency, safety, and regulatory alignment with both federal and military healthcare requirements. The agreement is structured as a subcontract under the NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, and is administered by the Defense Logistics Agency. The contract was posted on July 15, 2026, and is associated with the procurement vehicle SPE2DX25D8022 and delivery order SPE2D926F7369, indicating it is part of an ongoing logistical support effort for military medical supplies. While no specific place of performance or point of contact is provided, the obligation is tied to nationwide distribution in support of Department of Defense medical facilities. The absence of set-aside designation suggests this opportunity is open to all qualified vendors without restriction based on small business or other socio-economic criteria, emphasizing competitiveness and reliability in meeting critical operational medical needs.